Abstract
A better comprehension of the molecular mechanisms that take part in several neurodegenerative illnesses (such as Alzheimer and Parkinson's disease, lateral amyotrophic sclerosis, and so on) can aid in the development of new drugs and treatments. One of the main pathologic characteristics present in all of the previously cited disorders is the present of insoluble protein aggregates. For …